Brain-derived neurotrophic factor (BDNF), a member of the nerve growth factor (NGF) gene family, has been shown to influence the survival and differentiation of specific classes of neurons in vitro and in vivo. The possibility that neurotrophins are also involved in processes of neuronal plasticity has only recently begun to receive attention. To determine whether BDNF has a function in processes such as long-term potentiation (LTP), we produced a strain of mice with a deletion in the coding sequence of the BDNF gene. We then used hippocampal slices from these mice to investigate whether LTP was affected by this mutation. Homo-and heterozygous mutant mice showed significantly reduced LTP in the CAl region of the hippocampus. The magnitude of the potentiation, as well as the percentage of cases in which LTP could be induced successfully, was clearly affected. According to the criteria tested, important pharmacological, anatomical, and morphological parameters in the hippocampus of these animals appear to be normal. These results suggest that BDNF might have a functional role in the expression of LTP in the hippocampus.Neurotrophic factors, in particular the members of the nerve growth factor (NGF) gene family, have so far been considered predominantly with regard to their function in regulating survival and differentiation of specific neuronal populations during embryonic development and the maintenance of characteristic neuronal function in adulthood (1-3). There is, however, evidence that neurotrophins might also be involved in neuronal plasticity (4-10). Long-term potentiation (LTP) is the most widely used paradigm to study cellular and molecular events underlying neuronal plasticity (11). We therefore used this paradigm in slices of the hippocampus from mice with targeted deletion of the brain-derived neurotrophic factor (BDNF) gene to test whether BDNF has a role in this important phenomenon of synaptic plasticity. MATERIALS AND METHODSIn the gene-targeting construct, a 560-bp fragment from the BDNF protein-coding exon was replaced by the selection marker-a neomycin-resistance gene flanked by a glycerate kinase gene promoter and a polyadenylylation signal-thus deleting most of the mature BDNF coding sequence (Fig. 1). Embryonic stem cells (D3, 129Sv) containing the disrupted BDNF gene were injected into BALB/c mouse blastocysts for subsequent generation of chimeric mice. Chimeric males were crossed with NMRI females to produce heterozygotes. In keeping with previously published reports (12, 13), homozygous BDNF (-/-) mutant mice were retarded in growth and had reduced weight (down to only 25% of the wild type) from postnatal day 3 (P3) on. They displayed aberrant limb coordination and balance, showed a loss of neurons in the dorsal root ganglia, and usually died between 2 and 4 weeks after birth. Such abnormalities were never observed in heterozygous BDNF (+/ -) mice.Transverse hippocampal slices (400 ,um thick) were prepared and maintained by standard procedures (medium, 124 mM NaCl/3 mM KCl/1.25 mM...

Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body. A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely, is released on neuron depolarization, and triggers rapid intracellular signals and action potentials in central neurons. Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine. Using lesions and gene-targeted mice lacking BDNF, we show that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D3 receptor in nucleus accumbens both during development and in adulthood. BDNF from corticostriatal neurons also induces behavioural sensitization, by triggering overexpression of the D3 receptor in striatum of hemiparkinsonian rats. Our results suggest that BDNF may be an important determinant of pathophysiological conditions such as drug addiction, schizophrenia or Parkinson's disease, in which D3 receptor expression is abnormal.

No abstract

CILIARY neurotrophic factor (CNTF) supports the survival of embryonic motor neurons in vitrol,2 and in vivo 3 and prevents lesion-mediated degeneration of rat motor neuron~ during early post-natal stages 4• Here we report that CNTF greatly reduces all the functional and morphological changes in pmnlpmn mice 5 , an autosomal recessive mutant leading to progressive caudo-cranial motor neuron degeneration. The first manifestations of progressive motor neuronopathy in homozygous pmnl pmn mice become apparent in the hind limbs at the end of the third post-natal week and all the mice die up to 6 or 7 weeks after birth from respirato~ ~aralysis. Treatment .with CNTF p-rolongs-survival-and greatly Imp~oves ~otor functIon of these mice. Moreover, morphological mamfestatJons, such as loss of motor axons in the phrenic nerve and degeneration of facial motor neurons, were greatly reduced by CNTF, although the treatment did not start until the first symptoms of the disease had already become apparent and substan-' tial degenerative changes were already present. The protective and r~storative effects of CNTF in this mouse mutant give new perspectIves for the treatment of human degenerative motor neuron diseases with CNTF.We hav~ e~aluate~ the effects of CNTF in the pmn/ pmn mouse, whIch IS an ammal model for human spinal motor neuron disease 5 . In contrast to two other mouse mutants wobbler 6 -8 and mnd 9,1O, the manifestations of motor neuron d~generation in pmn/ pmn mice appear earlier and progress more rapidly. In 4-wee~-0Id pmn/ pmn mice, the number ofaxons of the phrenic nerve IS already highly reduced, indicating that at this time the Number of phrenic nerve axonsThe brain stem of mice perfused with 4% formaldehyde was embedded in paraffin, serial sections 7 -fLm thick were stained with cresyl violet, and the nucleoli of facial motor neurons were counted in every fifth section on both sides as previously described" Counts were not corrected for spl it nucleoli 4 ,15, The mean of the counts on both sides was used for each animal. Phrenic nerves were prepared after perfusion of the animals with 4% formalin, Nerves were postfixed in 4% formalin, dehydrated, then 5-fLm transverse sections made and stained according to ref, 16, Myelinated axons were counted from photographs taken from nerve sections under the light microscope, Data shown are means ± s,e.m, for each group, ND, not determined, * Statistical significance was tested by Student's t-test, P< 0,0005, 502 disease has already reached an advanced stage. The motor neurons of pmn/ pmn mice first undergo a reduction in cell size, then chromatolysis and finally cell death, similar to the pathological changes seen in many cases of human motor neuron diseases ll. The gene defect responsible for the motor neu'ron changes in pmn/ pmn mice is still unknown. But an insufficient or defective expression of CNTF does not seem to be responsible for the degenerative changes. Northern blots of sciatic nerve reveal CNTF transcripts with similar size and intensity to those of the h...

During development, Reelin acts on migrating neuronal precursors and controls correct cell positioning in the cortex and other brain structures by a hitherto unidentified mechanism. Here we show that in the postnatal mouse brain, Reelin acts as a detachment signal for chain-migrating interneuron precursors in the olfactory bulb. Neuronal precursors cultured in Matrigel detached from chains and migrated individually in the presence of exogenously added Reelin protein or Reelin-expressing brain tissues. Furthermore, we found that in reeler mutant mice, neuronal precursors accumulated in the olfactory bulb and remained in clusters, indicating that they did not change from tangential chain-migration to radial individual migration. Our data provide direct evidence that Reelin acts as a detachment signal, but not a stop or guidance cue. We propose that Reelin may have comparable functions during development.

Long-term potentiation (LTP) has been shown to be impaired in mice deficient in the brain-derived neurotrophic factor (BDNF) gene, as well as in a number of other knockout animals. Despite its power the gene-targeting approach is always fraught with the danger of looking at the cumulative direct and indirect effects of the absence of a particular gene rather than its immediate function. The re-expression of a specific gene at a selective time point and at a specific site in gene-defective mutants presents a potent procedure to overcome this limitation and to evaluate the causal relationship between the absence of a particular gene and the impairment of a function in gene-defective animals. Here we demonstrate that the re-expression of the BDNF gene in the CA1 region almost completely restores the severely impaired LTP in hippocampal slices of BDNF-deficient mice. The results therefore provide strong evidence for the direct involvement of BDNF in the process of LTP.

Gamma-Aminobutyric acid (GABA) switches from enhancing to repressing brain-derived neurotrophic factor (BDNF) mRNA synthesis during the maturation of hippocampal neurons in vitro. Interneurons do not produce BDNF themselves, but BDNF enhances their differentiation. Therefore, the question arose whether hippocampal interneurons regulate their phenotype by regulating BDNF expression and release from adjacent cells. The GABA(A) receptor agonist muscimol and BDNF increased the size and neuropeptide Y (NPY) immunoreactivity of hippocampal interneurons. However, GABAergic stimulation failed to increase NPY immunoreactivity in cultures from BDNF knockout embryos. At later developmental stages, when GABA represses BDNF synthesis, treatment with muscimol induced a decrease in cell size and NPY immunoreactivity of interneurons. Interneurons might thus control their phenotype through the regulation of BDNF synthesis in, and release from, their target neurons.

The sense of touch relies on detection of mechanical stimuli by specialized mechanosensory neurons. The scarcity of molecular data has made it difficult to analyze development of mechanoreceptors and to define the basis of their diversity and function. We show that the transcription factor c-Maf/c-MAF is crucial for mechanosensory function in mice and humans. The development and function of several rapidly adapting mechanoreceptor types are disrupted in c-Maf mutant mice. In particular, Pacinian corpuscles, a type of mechanoreceptor specialized to detect high-frequency vibrations, are severely atrophied. In line with this, sensitivity to high-frequency vibration is reduced in humans carrying a dominant mutation in the c-MAF gene. Thus, our work identifies a key transcription factor specifying development and function of mechanoreceptors and their end organs.